The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature

References

• TokluHZ, HussainA. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm. 2013;5(2):38–40. https://doi.org/10.1016/j.jyp.2012.09.001.
   PubMedGoogle Scholar
• World Health Organization. The Role of the Pharmacist in the Health Care System. World Health Organization, Geneva. 1994. http://apps.who.int/medicinedocs/en/d/Jh2995e/. Accessed 6 Sep 2017.
   Google Scholar
• World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2015 global survey. Global Survey. Geneva: World Health Organization, Noncommunicable Diseases and Mental Health; 2016.
   Google Scholar
• StawickiS, KalraS, JonesC, JustinianoC, PapadimosT, GalwankarS, et al. Comorbidity polypharmacy score and its clinical utility: a pragmatic practitioner’s perspective. J Emerg Trauma Shock. 2015;8(4):224–31. https://doi.org/10.4103/0974-2700.161658.
   PubMedGoogle Scholar
• GnjidicD, HilmerS, BlythF, NaganathanV, WaiteL, SeibelM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95. https://doi.org/10.1016/j.jclinepi.2012.02.018.
   PubMed Web of Science ®Google Scholar
• HubbardR, PeelN, ScottI, MartinJ, SmithA, PillansP, et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;7(202):373–7. https://doi.org/10.5694/mja13.00172.
   Google Scholar
• ReeveE, WieseMD. Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm. 2014;36(1):26–9. https://doi.org/10.1007/s11096-013-9871-z.
   PubMed Web of Science ®Google Scholar
• HamiltonHJ, GallagherPF, O’MahonyD. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9(1):5. https://doi.org/10.1186/1471-2318-9-5.
   PubMedGoogle Scholar
• World Health Organization. Adherence to long-term therapies: Evidence for action. Critical Review. Geneva: World Health Organization, Noncommuniclable Diseases; 2003.
   Google Scholar
• RougheadL, SempleS, RosenfeldE. Literature review: medication safety in Australia. Sydney: Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute University of South Australia; 2013.
   Google Scholar
• RougheadEE, SempleSJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008. Aust New Zealand Health Policy. 2009;6(1):18. https://doi.org/10.1186/1743-8462-6-18.
   PubMedGoogle Scholar
• Pharmacy Guild of Australia. About the Guild. The Pharmacy Guild of Australia. 2017. https://www.guild.org.au/about-us. Accessed 27 Mar 2018.
   Google Scholar
• Pharmacy Guild of Australia. Community Pharmacy Agreement. Pharmacy Guild of Australia. 2017. https://www.guild.org.au/migration/community-pharmacy-agreement. Accessed 15 Mar 2017.
   Google Scholar
• CooperHM. Organizing knowledge syntheses: a taxonomy of literature reviews. Knowl Soc. 1988;1(1):104.
   Google Scholar
• BaumeisterRF, LearyMR. Writing narrative literature reviews. Rev Gen Psychol. 1997;1(3):311.
   Google Scholar
• Valentijn PP, Schepman SM, Opheij W, Bruijnzeels MA. Understanding integrated care: a comprehensive conceptual framework based on the integrative functions of primary care. Int J Integr Care. 2013;13. http://doi.org/10.5334/ijic.886.
   Google Scholar
• StarfieldB. Primary care: concept, evaluation, and policy. USA: Oxford University Press; 1992.
   Google Scholar
• StarfieldB, ShiL, MacinkoJ. Contribution of primary care to health systems and health. Milbank Q. 2005;83(3):457–502.
   PubMed Web of Science ®Google Scholar
• Pharmacy Guild of Australia. Programme Specific Guidelines Pharmacy Practice Incentives (PPI). Canberra: Pharmacy Guild of Australia and Australian Government Department of Health; 2014. p. 1–15.
   Google Scholar
• Pharmaceutical Society of Australia. Guidelines for pharmacists providing medicines use review and diabetes medication management services. Canberra: Pharmaceutical Society of Australia Ltd.; 2011. p. 1–26.
   Google Scholar
• Pharmaceutical Society of Australia. Standards and Guidelines for pharmacists performing clinical interventions. Canberra: Pharmaceutical Society of Australia Ltd.; 2011. p. 1–32.
   Google Scholar
• WilliamsM, PetersonGM, TenniPC, BindoffIK, StaffordAC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34(1):43–52. https://doi.org/10.1007/s11096-011-9583-1.
   PubMed Web of Science ®Google Scholar
• The 6CPA. MedsCheck and Diabetes MedsCheck. The 6CPA. 2015. http://6cpa.com.au/medication-management-programmes/medscheck-diabetes-medscheck/. Accessed 15 Aug 2017.
   Google Scholar
• Department of Health. Medication Management Reviews. Australian Government Department of Health. 2014. http://www.health.gov.au/internet/main/publishing.nsf/Content/medication_management_reviews.htm. Accessed 15 Mar 2017.
   Google Scholar
• PricewaterhouseCoopers. Combined Review 5CPA Medication Management Programmes. Review. Canberra: Australian Government, Department of Health; 2015.
   Google Scholar
• JokanovicN, TanEC, SudhakaranS, KirkpatrickCM, DooleyMJ, Ryan-AtwoodTE, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–85. https://doi.org/10.1016/j.sapharm.2016.08.005.
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Society of Australia. Guidelines for pharmacists providing Home Medicines Review (HMR) services. Canberra: Pharmaceutical Society of Australia Ltd.; 2011. p. 1–20.
   Google Scholar
• MalekJ. HMR and RMMR program changes. Aust Pharm. 2011;30(10):848–50.
   Google Scholar
• JokanovicN, TanECK, van den BoschD, KirkpatrickCM, DooleyMJ, BellJS. Clinical medication review in Australia: a systematic review. Res Social Adm Pharm. 2016;12(3):384–418. https://doi.org/10.1016/j.sapharm.2015.06.007.
   PubMed Web of Science ®Google Scholar
• ChenTF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging. 2016;33(3):199–204. https://doi.org/10.1007/s40266-016-0357-2.
   PubMed Web of Science ®Google Scholar
• The 6CPA. Home Medicines Review. The 6CPA. 2015. http://6cpa.com.au/medication-management-programs/home-medicines-review/. Accessed 17 Aug 2017.
   Google Scholar
• NauntonM, PetersonGM. Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital. J Pharm Pract Res. 2003;33(3):176–82. https://doi.org/10.1002/jppr2003333176.
   Google Scholar
• SchnipperJL, KirwinJL, CotugnoMC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565–71. https://doi.org/10.1001/archinte.166.5.565.
   PubMedGoogle Scholar
• ArnoldME, BuysL, FullasF. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate. Am J Health Syst Pharm. 2015;72(11 Supplement 1):S36–42. https://doi.org/10.2146/sp150011.
   PubMed Web of Science ®Google Scholar
• The 6CPA. Important: 6CPA program changes from 1 July 2017. The 6CPA 2017. http://6cpa.com.au/2017/06/important-6cpa-program-changes-from-1-july-2017/. Accessed 18 Aug 2017.
   Google Scholar
• MossialosE, CourtinE, NaciH, BenrimojS, BouvyM, FarrisK, et al. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628–39. https://doi.org/10.1016/j.healthpol.2015.02.007.
   PubMed Web of Science ®Google Scholar
• ForouzanfarMH, AfshinA, AlexanderLT, AndersonHR, BhuttaZA, BiryukovS, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1659–724. https://doi.org/10.1016/S0140-6736(16)31679-8.
   PubMed Web of Science ®Google Scholar
• SabaM, DiepJ, SainiB, DhippayomT. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther. 2014;39(3):240–7. https://doi.org/10.1111/jcpt.12131.
   PubMed Web of Science ®Google Scholar
• Brown TJ, Todd A, O’Malley C, Moore HJ, Husband AK, Bambra C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6(2) https://doi.org/10.1136/bmjopen-2015-009828.
   Google Scholar
• GreenhalghE, StillmanS, FordC. Pharmacotherapies. In: ScolloM, WinstanleyM, editors. Tobacco in Australia: facts and issues. Melbourne: Cancer Council Australia; 2016.
   Google Scholar
• Pharmacy Guild of Australia. Vaccination Services. The Pharmacy Guild of Australia. 2017. https://www.guild.org.au/programs/vaccination-services. Accessed 26 Aug 2017.
   Google Scholar
• BursonRC, ButtenheimAM, ArmstrongA, FeemsterKA. Community pharmacies as sites of adult vaccination: a systematic review. Hum Vaccin Immunother. 2016;12(12):3146–59. https://doi.org/10.1080/21645515.2016.1215393.
   PubMed Web of Science ®Google Scholar
• NissenL, GlassB, LauE, RosenthalM. Queensland pharmacist immunisation pilot phase 1 pharmacist vaccination - influenza. Final report. Brisbane: Queensland University of Technology, Faculty of Health; 2015.
   Google Scholar
• Hattingh HL, Sim TF, Parsons R, Czarniak P, Vickery A, Ayadurai S. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study. BMJ Open. 2016;6(9) https://doi.org/10.1136/bmjopen-2016-011948.
   Google Scholar
• National Health Priority Action Council. National Chronic Disease Strategy. Canberra: National Health Priority Action Council, Australian Government Department of Health and Ageing; 2006. p. 1–6.
   Google Scholar
• Australian Institue of Health and Welfare. Cardiovascular disease, diabetes and chronic kidney disease - Australian facts: Prevalence and Incidence. 2 ed. Canberra: Australian Institue of Health and Welfare; 2014.
   Google Scholar
• Sabater-HernándezD, Sabater-GalindoM, Fernandez-LlimosF, RottaI, HossainLN, DurksD, et al. A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease. J Manag Care Spec Pharm. 2016;22(6):699–713. https://doi.org/10.18553/jmcp.2016.22.6.699.
   PubMedGoogle Scholar
• SennaG, CaminatiM, BovoC, CanonicaGW, PassalacquaG. The role of the pharmacy in the management of bronchial asthma: a literature-based evaluation. Ann Allergy Asthma Immunol. 2017;118(2):161–5. https://doi.org/10.1016/j.anai.2016.10.019.
   PubMed Web of Science ®Google Scholar
• Garcia-CardenasV, ArmourC, BenrimojSI, Martinez-MartinezF, RottaI, Fernandez-LlimosF. Pharmacists’ interventions on clinical asthma outcomes: a systematic review. Eur Respir J. 2016;47(4):1134–43. https://doi.org/10.1183/13993003.01497-2015.
   PubMed Web of Science ®Google Scholar
• Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010; https://doi.org/10.1002/14651858.CD000336.pub2.
   Google Scholar
• HattinghHL, ScahillS, FowlerJL, WheelerAJ. Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature. J Ment Health. 2016;25(6):550–9. https://doi.org/10.3109/09638237.2015.1101418.
   PubMed Web of Science ®Google Scholar
• Health Outcomes International Pty Ltd. Return on Investment in Needle and Syringe Programs in Australia. Econmic Effectiveness Report. Canberra: Commonwealth of Australia, Department of Health and Ageing; 2002.
   Google Scholar
• GowingL, AliR, DunlopA, FarrellM, LintzerisN. National Guidelines for medication-assisted treatment of opioid dependence. National Guideline. Canberra: Australian Government, Department of Health; 2014.
   Google Scholar
• MacArthurGJ, van VelzenE, PalmateerN, KimberJ, PharrisA, HopeV, et al. Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34–52. https://doi.org/10.1016/j.drugpo.2013.07.001.
   PubMed Web of Science ®Google Scholar
• Pricolo A, Nielsen S. Naloxone rescheduling in Australia: processes, implementation and challenges with supply of naloxone as a ‘pharmacist only’ over-the-counter medicine. Drug Alcohol Rev. 2017; https://doi.org/10.1111/dar.12547.
   Google Scholar
• RobertsA, BenrimojS, ChenT, WilliamsK, AslaniP. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8. https://doi.org/10.1345/aph.1K617.
   PubMed Web of Science ®Google Scholar
• RosenthalM, AustinZ, TsuyukiRT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143(1):37–42. https://doi.org/10.3821/1913-701X-143.1.37.
   Google Scholar
• EadesCE, FergusonJS, O’CarrollRE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582. https://doi.org/10.1186/1471-2458-11-582.
   PubMed Web of Science ®Google Scholar
• WillisA, RiversP, GrayLJ, DaviesM, KhuntiK. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS One. 2014;9(4):e91157. https://doi.org/10.1371/journal.pone.0091157.
   PubMed Web of Science ®Google Scholar
• GoldwaterJ, YuhaszL. Considerations for clinical integration. Insight paper. Michigan: IBM Watson Health, Truven Health Analytics; 2011.
   Google Scholar
• Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L, et al. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017;7(9) https://doi.org/10.1136/bmjopen-2016-015471.
   Google Scholar
• SupperI, CatalaO, LustmanM, ChemlaC, BourgueilY, LetrilliartL. Interprofessional collaboration in primary health care: a review of facilitators and barriers perceived by involved actors. J Public Health. 2015;37(4):716–27. https://doi.org/10.1093/pubmed/fdu102.
   Web of Science ®Google Scholar
• Mulvale G, Embrett M, Razavi SD. ‘Gearing Up’ to improve interprofessional collaboration in primary care: a systematic review and conceptual framework. BMC Fam Pract. 2016;17(1):83. https://doi.org/10.1186/s12875-016-0492-1.
   PubMedGoogle Scholar
• Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, et al. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. 2014; https://doi.org/10.1002/14651858.CD007768.pub3.
   Google Scholar
• TanECK, StewartK, ElliottRA, GeorgeJ. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608–22. https://doi.org/10.1016/j.sapharm.2013.08.006.
   PubMed Web of Science ®Google Scholar
• HazenACM, de BontAA, BoelmanL, ZwartDLM, de GierJJ, de WitNJ, et al. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: a systematic review. Res Social Adm Pharm. 2018;14(3):228–40. https://doi.org/10.1016/j.sapharm.2017.04.014.
   PubMed Web of Science ®Google Scholar
• LeutzWN. Five Laws for integrating medical and social services: lessons from the United States and the United Kingdom. Milbank Q. 1999;77(1):77–110. https://doi.org/10.1111/1468-0009.00125.
   PubMed Web of Science ®Google Scholar
• AhgrenB, AxelssonR. Evaluating integrated health care: a model for measurement. Int J Integr Care. 2005;5:e01.
   PubMedGoogle Scholar
• HernandezSR. Horizontal and vertical healthcare integration: lessons learned from the United States. Healthc Pap. 2000;1(2):59–65.
   PubMedGoogle Scholar
• ChuiMA, MottDA, MaxwellL. A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach. Res Social Adm Pharm. 2012;8(3):206–16. https://doi.org/10.1016/j.sapharm.2011.06.001.
   PubMed Web of Science ®Google Scholar
• EmersonL. PSA roadshow launches health destination pharmacy. Aust Pharm. 2016;35(5):15.
   Google Scholar
• Pharmaceutical Society of Australia. Why - Give your pharmacy the plus factor. Pharmaceutical Society of Australia, Canberra, Australia. 2018. www.healthdestinationpharmacy.com.au/why/. Accessed 12 June 2018.
   Google Scholar
• EmersonL. A ground-breaking year and exciting times ahead. Aust Pharm. 2017;36(1):8–10.
   Google Scholar